LegoChem Biosciences Inc

141080 · KQ · Healthcare / Biotechnology

62,200.00KRW-1000.00 (-1.58%)

Price History

Full chart

Market Stats

Previous Close63,200.00

Open63,900.00

Day Range61,800.00 – 68,200.00

52-Week Range60,400.00 – 225,000.00

Volume205.40K

Market Cap2.27T

P/E (TTM)0.00

Forward P/E0.00

EPS-4,850.39

Dividend Yield0.00%

Beta0.49

50-Day Avg81,704.00

200-Day Avg141,025.50

About

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Sejin Park M.B.A.
Employees183
Headquarters10, Gukjegwahak 10-ro, Daejeon, South Korea, 34002, Korea
Websitehttps://ligachembio.com

Leadership

Mr. Sejin Park M.B.A.CEO, President & Director · b. 1962
Dr. Chul-Woong Chung Ph.D.MD & Head of the ADC Research Institute
Jasung KuDirector of the CMC Center
Dr. Jinhwan Han Ph.D.MD & C.T.O.
Dr. Young-Lag Cho Ph.D.Senior VP & Chief Development Division
Dr. Rodrigo Ruiz Soto M.D.Chief Medical Officer
Sechang AhnDirector of Process Center

Financials

Income Statement

Currency: KRW	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	870.05M	1.79B	16.66B	22.06B	25.24B	57.50B	49.39B	32.16B	33.41B	34.15B	125.90B	141.55B
Growth (%)	-	+105.56%	+831.27%	+32.43%	+14.43%	+127.81%	-14.10%	-34.90%	+3.90%	+2.20%	+268.71%	+12.43%
Cost of Revenue	0	690.92M	12.46B	15.34B	19.33B	22.69B	13.83B	14.46B	15.56B	16.35B	15.95B	15.56B
Gross Profit	870.05M	1.10B	4.19B	6.72B	5.91B	34.81B	35.56B	17.70B	17.85B	17.80B	109.95B	126.00B
Gross Margin	100.00%	61.37%	25.17%	30.47%	23.41%	60.54%	72.00%	55.03%	53.42%	52.12%	87.33%	89.01%
Operating Expense	9.33B	9.15B	19.02B	19.43B	33.35B	26.39B	65.06B	44.49B	68.46B	98.95B	130.90B	232.48B
Operating Income	-8.46B	-8.05B	-14.82B	-12.71B	-27.44B	8.42B	-29.49B	-26.80B	-50.61B	-81.15B	-20.95B	-106.49B
Operating Margin	-972.01%	-450.04%	-89.00%	-57.62%	-108.73%	14.64%	-59.71%	-83.33%	-151.49%	-237.67%	-16.64%	-75.23%
EBITDA	-	-	-	-	-	-	-	-	-43.32B	-70.55B	14.64B	-86.40B
EBITDA Margin	-	-	-	-	-	-	-	-	-129.65%	-206.60%	11.63%	-61.04%
Net Income	-8.69B	-8.24B	-14.72B	-12.93B	-25.77B	13.59B	-6.99B	-23.39B	-45.09B	-73.70B	7.80B	-74.28B
Net Income Margin	-998.29%	-460.58%	-88.41%	-58.64%	-102.10%	23.63%	-14.14%	-72.74%	-134.96%	-215.85%	6.20%	-52.47%
R&D	7.68B	7.00B	7.81B	9.26B	15.51B	16.71B	54.20B	39.07B	51.11B	79.61B	113.19B	216.91B
R&D as % of Total Revenue	882.62%	391.42%	46.91%	42.00%	61.43%	29.06%	109.74%	121.50%	152.97%	233.14%	89.90%	153.23%
Interest Expense	0	0	0	0	0	25.80M	0	68.77M	285.75M	528.26M	503.21M	883.19M
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%	0.00%	0.21%	0.86%	1.55%	0.40%	0.62%

Balance Sheet

Currency: KRW	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	33.76B	68.44B	89.55B	82.24B	121.69B	141.48B	135.91B	293.23B	252.53B	189.50B	738.38B	701.81B
Total Liabilities	13.71B	25.26B	29.49B	34.03B	20.02B	27.73B	23.79B	34.46B	32.93B	41.28B	122.38B	160.69B
Total Equity	20.04B	43.18B	60.06B	48.21B	101.66B	113.75B	112.13B	258.77B	219.60B	148.22B	616.00B	507.61B
Cash	1.62B	2.06B	142.36M	11.07K	520.23M	6.25B	44.24B	49.68M	117.96B	63.05B	128.91B	98.65B
Total Debt	-	11.63B	9.09B	9.76B	-	2.07B	3.91B	-	-	-	-	-

Cash Flow

Currency: KRW	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-7.88B	-8.54B	-13.04B	-8.21B	-12.76B	24.11B	-14.89B	-42.05B	-7.14B	-62.24B	78.48B	-124.53B
Investing Cash Flow	-10.92B	9.17B	-20.15B	11.89B	-50.58B	29.97B	349.13M	-43.94B	-16.17B	9.37B	-457.37B	-
Financing Cash Flow	19.08B	189.49M	33.72B	1.98B	64.94B	2.60B	2.63B	171.29B	3.20B	-1.91B	443.38B	-
Capital Expenditure	290.50M	365.01M	4.24B	2.20B	3.76B	3.37B	3.22B	18.31B	4.16B	2.20B	5.70B	6.04B
Free Cash Flow	-	-	-	-	-	-	-18.11B	-38.29B	-11.91B	-64.44B	72.78B	-130.57B
FCF to OCF	-	-	-	-	-	-	121.61%	91.06%	166.88%	103.54%	92.74%	104.85%

Earnings

Report Date	Jun 30, 2013	Sep 30, 2013	Dec 31, 2013	Mar 31, 2014	Aug 14, 2014	Nov 16, 2014	Feb 17, 2015	May 18, 2015	Aug 18, 2015	Nov 16, 2015	Feb 26, 2016	Apr 27, 2016	Aug 26, 2016	Nov 28, 2016	Mar 7, 2017	May 26, 2017	Aug 25, 2017	Nov 28, 2017	Feb 26, 2018	May 15, 2018	Aug 14, 2018	Nov 14, 2018	Mar 8, 2019	May 15, 2019	Aug 13, 2019	Nov 5, 2019	Feb 10, 2020	May 15, 2020	Aug 12, 2020	Nov 13, 2020	Mar 23, 2021	May 14, 2021	Aug 17, 2021	Nov 15, 2021	Mar 23, 2022	May 13, 2022	Aug 16, 2022	Nov 14, 2022	Mar 15, 2023	May 15, 2023	Aug 11, 2023	Nov 14, 2023	Mar 14, 2024	May 16, 2024	Aug 14, 2024	Nov 12, 2024	Feb 14, 2025	May 15, 2025	Aug 14, 2025	Nov 13, 2025	Mar 23, 2026	May 15, 2026	Aug 14, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	130.13	-	-	349.13	326.31	354.54	941.93	-365.26	-608.12
EPS Actual	-122.20	-97.08	-141.50	-109.21	-124.01	-148.40	-219.00	-149.71	-143.79	-126.71	-98.86	-95.49	-147.37	-109.98	-411.59	-160.24	-122.35	-97.48	-269.78	-110.17	-47.19	-309.92	-751.68	13.57	-95.42	782.25	-59.34	-138.50	276.00	-227.00	-104.31	-558.00	-649.00	-363.00	594.95	-351.00	-322.00	-135.00	-1036.31	-675.39	-756.54	-749.25	-577.25	328.05	-204.39	308.83	-149.36	721.00	-840.00	-431.00	-1492.00	-1024.00	-1934.00
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-257.06%	-	-	106.51%	-357.42%	-221.57%	-258.40%	-180.35%	-218.03%
Timing	-	-	-	-	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	After-hours	Pre-market	After-hours	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	-	Pre-market	After-hours	Pre-market	-	Pre-market

Key Statistics & Ratios

Market Cap2.27T

Enterprise Value1.88T

Trailing P/E0.00

Forward P/E0.00

Price / Sales22.94

Price / Book5.66

EPS-4,850.39

Book Value10,859.42

Revenue (TTM)98.78B

Gross Profit (TTM)86.55B

EBITDA-198.89B

Profit Margin-180.94%

Operating Margin-1300.89%

Return on Equity-36.55%

Return on Assets-19.81%

Shares Outstanding36.85M

Shares Float25.38M

Beta0.49

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Jun 16, 20202:1